CNS pipeline · person

Stephen R. Marder, M.D.

Member of the BioXcel Therapeutics Neuroscience Clinical Advisory Board (formed 2018 for BXCL501). Daniel X. Freedman Professor of Psychiatry and Vice Chair for Education at the UCLA Semel Institute; an expert in CNS clinical trials methodology, particularly in schizophrenia.

  • 0 companies

Past roles

People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.